NIH-funded research NIH-funded research

Using health records to better identify and understand substance use disorders

Official title: Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping

Funded at Vanderbilt University Medical Center · NIH-11171719 · Data updated 2026-11-12

This project builds tools that use electronic health records to more accurately find people with substance use problems so researchers can study genetic contributors.

More Substance Use research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2022
Project endJuly 31, 2027
Funding year2025
Award (this year)$525,000
NIH project number5DP1DA056667-05
Project IDNIH-11171719 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with a history of substance use whose electronic health records (and where available, genetic data) are accessible to participating health systems.

Less likely to help

People without linked medical records or genetic data, or those not seen at participating hospitals, are unlikely to be involved or to see direct benefits from this project.

What this research studies

You should know this project creates a system that combines billing codes, medication records, and doctors' notes to give a probability score for substance use disorder instead of a simple yes/no label. The team will test the method across multiple hospitals and make it customizable for different research needs. They will link these refined health-record profiles to genetic data to look for inherited risk factors. The goal is to make the method portable so other centers can use it to support larger genetic studies.

Why it matters

Potential benefit: If successful, this work could speed discovery of genetic risks for addiction and help develop risk scores or clinical tools to guide prevention and treatment.

How similar studies have gone: EHR-based phenotyping and genetics studies have worked well for some conditions, but applying a multi-source probabilistic approach specifically to substance use disorders is relatively new.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Jeffery, Alvin Dean — Vanderbilt University Medical Center
  • Study coordinator: Jeffery, Alvin Dean

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.